论文部分内容阅读
目的:分析华蟾素联合化疗治疗非小细胞肺癌的临床效果。方法:选择本院接受治疗的非小细胞肺癌患者75例,根据患者治疗方式不同分为两组,其中36例对照组患者采用常规化疗,39例观察组患者采用常规化疗时联合华蟾素治疗。结果:观察组患者临床近期疗效总有效率、2年生存率及生存质量提高率较对照组高,不良反应发生率较对照组低(P<0.05)。结论:华蟾素联合化疗治疗非小细胞肺癌取得让人满意效果。
Objective: To analyze the clinical effect of cinobufacini combined with chemotherapy in the treatment of non-small cell lung cancer. Methods: Seventy-five patients with non-small cell lung cancer who were treated in our hospital were divided into two groups according to their different treatment methods. Among them, 36 patients in the control group received routine chemotherapy and 39 patients in the observation group received conventional cinobufotalin combined with chemotherapy . Results: The total effective rate, 2-year survival rate and quality of life improvement rate in the observation group were higher than those in the control group. The incidence of adverse reactions was lower in the observation group than in the control group (P <0.05). Conclusion: Cinobufotalin combined with chemotherapy has achieved satisfactory results in non-small cell lung cancer.